Atrás
Rango del Día
$334.83
$337.81
Rango de 52 Semanas
$221.26
$362.41
Volumen
573,398
Promedio 50D / 200D
$341.27
/
$283.75
Cierre Anterior
$335.85
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 74.1 | 0.4 |
| P/B | 9.2 | 2.9 |
| ROE % | 13.8 | 3.8 |
| Net Margin % | 12.7 | 3.9 |
| Rev Growth 5Y % | 17.1 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$371.92
+10.8%
Low: $349.00
High: $388.00
P/E Futuro
66.8
EPS Futuro
$5.02
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
1.6 B
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2029 |
$9.25
$8.93 – $9.57
|
2.3 B | 2 |
| FY2028 |
$7.60
$7.03 – $8.91
|
2 B | 4 |
| FY2027 |
$6.37
$5.47 – $6.90
|
1.8 B | 11 |
Puntos Clave
Revenue grew 17.06% annually over 5 years — strong growth
Earnings grew 1168.11% over the past year
ROE of 13.78% — decent returns on equity
Debt/Equity of 0.15 — conservative balance sheet
Generating 174.93M in free cash flow
P/E of 74.11 — premium valuation
Crecimiento
Revenue Growth (5Y)
17.06%
Revenue (1Y)17.50%
Earnings (1Y)1168.11%
FCF Growth (3Y)45.95%
Calidad
Return on Equity
13.78%
ROIC8.62%
Net Margin12.66%
Op. Margin13.48%
Seguridad
Debt / Equity
0.15
Current Ratio6.64
Interest Coverage0.00
Valoración
P/E Ratio
74.11
P/B Ratio9.22
EV/EBITDA69.76
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.50% | Revenue Growth (3Y) | 15.15% |
| Earnings Growth (1Y) | 1168.11% | Earnings Growth (3Y) | 39.77% |
| Revenue Growth (5Y) | 17.06% | Earnings Growth (5Y) | 140.81% |
| Profitability | |||
| Revenue (TTM) | 1.40B | Net Income (TTM) | 177.69M |
| ROE | 13.78% | ROA | 9.73% |
| Gross Margin | 67.14% | Operating Margin | 13.48% |
| Net Margin | 12.66% | Free Cash Flow (TTM) | 174.93M |
| ROIC | 8.62% | FCF Growth (3Y) | 45.95% |
| Safety | |||
| Debt / Equity | 0.15 | Current Ratio | 6.64 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 74.11 | P/B Ratio | 9.22 |
| P/S Ratio | 9.38 | PEG Ratio | 0.06 |
| EV/EBITDA | 69.76 | Dividend Yield | 0.00% |
| Market Cap | 13.17B | Enterprise Value | 13.20B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.40B | 1.19B | 1.06B | 847.13M | 747.59M |
| Net Income | 177.69M | 14.01M | 90.95M | -2.00M | 5.28M |
| EPS (Diluted) | 4.52 | 0.36 | 2.32 | -0.05 | 0.14 |
| Gross Profit | 942.44M | 755.00M | 682.64M | 535.21M | 475.38M |
| Operating Income | 189.25M | 9.28M | 73.55M | 6.08M | -7.50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.83B | 1.53B | 1.56B | 1.37B | 1.24B |
| Total Liabilities | 398.92M | 382.25M | 377.36M | 372.03M | 290.32M |
| Shareholders' Equity | 1.43B | 1.15B | 1.18B | 998.86M | 953.93M |
| Total Debt | 219.70M | 223.39M | 234.34M | 235.77M | 173.55M |
| Cash & Equivalents | 186.90M | 324.40M | 167.49M | 69.86M | 59.38M |
| Current Assets | 1.22B | 951.13M | 915.40M | 755.70M | 681.47M |
| Current Liabilities | 183.13M | 158.35M | 151.14M | 144.93M | 123.20M |